77272 подписчиков
252 видео
The Mexico City story: Proud hosts of the 10th IAS Conference on HIV Science (IAS 2019)
On-demand Oral TDF/FTC for PrEP: Is It an Option?
Challenges and Opportunities in HIV Science
Welcome to Paris - IAS 2017
TUAB0102 - Switching from a tenofovir disoproxil fumarate (TDF)-based regimen to a tenofovir ...
TUAB0101 - Atazanavir/ritonavir 200/100 mg is non-inferior to atazanavir/ritonavir 300/100 mg ...
Primary HIV Infection and Early Treatment
Broadly Neutralizing Antibodies against HIV
Antiretroviral Therapy - ART: Season One
Plenary Session
IAS 2017 Rapporteur and Closing Session
Antiretroviral Therapy - ART: Season Two
The Missing Men
